Correction to: Non-vitamin K antagonist oral anticoagulants in patients with an increased risk of bleeding

Thomas Gremmel; Alexander Niessner; Hans Domanovits; Martin Frossard; Gürkan Sengölge; Barbara Steinlechner; Thomas Sycha; Michael Wolzt; Ingrid Pabinger

doi:10.1007/s00508-019-1467-8

Correction to: Non-vitamin K antagonist oral anticoagulants in patients with an increased risk of bleeding

Wien Klin Wochenschr. 2019 Mar;131(5-6):135. doi: 10.1007/s00508-019-1467-8.

Authors

Thomas Gremmel^{1

2}, Alexander Niessner³, Hans Domanovits⁴, Martin Frossard⁵, Gürkan Sengölge⁶, Barbara Steinlechner⁷, Thomas Sycha⁸, Michael Wolzt⁹, Ingrid Pabinger¹⁰

Affiliations

¹ Department of Internal Medicine II, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria. thomas.gremmel@meduniwien.ac.at.
² Department of Internal Medicine, Cardiology and Nephrology, Landesklinikum Wiener Neustadt, Wiener Neustadt, Austria. thomas.gremmel@meduniwien.ac.at.
³ Department of Internal Medicine II, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria. alexander.niessner@meduniwien.ac.at.
⁴ Department of Emergency Medicine, Medical University of Vienna, Vienna, Austria.
⁵ Department of Trauma Surgery, Medical University of Vienna, Vienna, Austria.
⁶ Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
⁷ Department of Anesthesia, Intensive Care Medicine and Pain Medicine, Medical University of Vienna, Vienna, Austria.
⁸ Department of Neurology, Medical University of Vienna, Vienna, Austria.
⁹ Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
¹⁰ Department of Internal Medicine I, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria. ingrid.pabinger@meduniwien.ac.at.

Abstract

Correction to: Wien Klin Wochenschr 2018 https://doi.org/10.1007/s00508-018-1381-5 Unfortunately, the original version of this article contained two mistakes.The text passage "It should be mentioned here that in the case of apixaban, dose adjustment is not based on GFR. A lower dosage of apixaban ….

Publication types

Published Erratum